Our Services

Health Economics Research

At Medicys we partner with, and are preferred suppliers to, many leading health economics firms who focus on measuring and valuing the outcomes of healthcare interventions and who seek to understand how to navigate regulatory frameworks and Health Technology Assessment processes.

Specifically, our pricing and market access specialists recruit, interview and report on our network of local, regional and national payers (and ex payers) and Payer Advising Key Opinion Leaders (PA-KOLs) on topics such as:

  • Economic Evaluation
  • Cost of illness
  • Cost comparison, effectiveness, utility and benefit
  • Thresholds and opportunity costs
  • Value driven healthcare systems
  • Health Policy and Regulatory frameworks
  • Approval and labelling
  • Pricing Policy and pricing Schemes
  • Reimbursement and access
  • Insurance systems and national healthcare
  • Public spending and national health expenditures
  • Procurement systems
  • Risk sharing approaches
  • Health Technology Assessment
  • Systems and structure
  • Value framework and dossier format
  • Decisions and deliberative processes

Our projects in this discipline usually take the form of Web Assisted Telephone Depth Interviews (WATDIs), online groups or advisory boards (digital or in person).

Related Work

health economics research

Therapy Area: Respiratory diseases
Topic: COPD

Chronic Obstructive Pulmonary Disease

Respondent Type: Regional and national payers

Assess unmet need for treatment of muscle weakness in COPD and pricing opportunity for novel asset

Countries:
Sample Size: 12
Methodology: 30 minute Web Assisted Telephone Depth Interviews (WATDIs)
Services Delivered: Recruitment, moderation, content analyses

health economics research

Therapy Area: Respiratory diseases
Topic: COVID-19
Respondent Type: Payers

+2

Key Opinion Leaders (KOLs), respiratory physicians

Talking to key decision makers in the area of respiratory infections, specifically SARS-CoV2, respiratory pandemics and also infectious rhinitis and rhinosinusitis. Understand views on the treatment and management of respiratory infections, and the impact that a new treatment may have on this therapeutic area in the future. Discuss the potential pricing and reimbursement implications a new product may have on this therapy area

Countries:
Sample Size: 17
Methodology: 30 minute Web Assisted Telephone Depth Interviews (WATDIs)
Services Delivered: Recruitment, Moderation, Transcripts

health economics research

Therapy Area: Hepatology
Topic: AAH

Acute Alcoholic Hepatitis

Respondent Type: National payers

To assess the unmet need, value perception, and pricing and market access potential of a drug in clinical development

Countries:
Sample Size: 27
Methodology: 15 minute pre-read and 60 minute Web Assisted Telephone Depth Interviews (WATDIs)
Services Delivered: Translations, recruitment, moderation, transcripts

health economics research

Therapy Area: Oncology
Topic: G-CSF pricing

Granulocyte-Colony Stimulating Factor

Respondent Type: Local payers

Understand negotiations on originators and biosimilars with pharmaceutical companies and awareness of discounts obtained after pricing negotiations

Countries:
Sample Size: 38
Methodology: 30 minute Computer Aided Telephone Interviews (CATIs)
Services Delivered: Scripting, hosting, translations, recruitment, moderation

Request a quote